Local radiotherapy

RADIATION5 trials

Conditions

Carcinoma, Non-Small-Cell LungColorectal NeoplasmsEffects of ChemotherapyLocal Neoplasm RecurrenceLymphomaLymphoma, Non-HodgkinLymphomas: Non-HodgkinLymphomas: Non-Hodgkin Follicular / Indolent B-Cell

Phase 2

A Phase 2 Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas

CompletedNCT00880581

Ronald LevyLymphoma, Lymphoma, Non-Hodgkin, Lymphomas: Non-Hodgkin +1

Start: 2009-01-31End: 2015-01-31Updated: 2017-03-14

Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery

RecruitingNCT05973864

UNICANCERTriple Negative Breast Neoplasms

Start: 2025-03-11End: 2028-08-31Target: 220Updated: 2025-11-17

Phase 3

Perioperative FOLFIRI VS Adjuvant FOLFIRI in Resectable Advanced CRC Failed to Oxaliplatin

NCT02087475

Sixth Affiliated Hospital, Sun Yat-sen UniversityColorectal Neoplasms, Effects of Chemotherapy, Local Neoplasm Recurrence +2

Start: 2011-01-31End: 2024-12-31Target: 360Updated: 2019-06-05

Phase 4

Apatinib and radiotherapy Compared with zoledronic acid and radiotherapy Treatment in Patients With bone metastases of Malignant tumor

RecruitingChiCTR-IPR-17010456

Da Hospitalcancer

Start: 2017-01-01Updated: 2017-04-18

Unknown Phase

Chemotherapy Combination With Local Radiotherapy and rhGM-CSF for Oligometastatic Stage IV NSCLC Patients

NCT03489616

Shandong Cancer Hospital and InstituteCarcinoma, Non-Small-Cell Lung

Start: 2018-01-15End: 2019-12-31Target: 45Updated: 2018-04-05

Related Papers

Activity of a Sting and a TLR9 Agonist As an “in Situ Therapeutic Vaccination” Against Lymphomas

Blood2016-12-021 citations

Natural Toll-like Receptor Agonists for in Situ Vaccination Lymphoma Immunotherapy

Blood2015-12-03

Dose-Escalated, Intratumoral TLR9 Agonist and Low-Dose Radiation Induce Abscopal Effects in Follicular Lymphoma

Blood2014-12-0612 citations